Immunology studies in non‐human primate models of tuberculosis
Year: 2015
Type: review
Abstract: Non-human primates, primarily macaques, have been used to study tuberculosis for decades. However, in the last 15 years, this model has been refined substantially to allow careful investigations of the immune response and host-pathogen interactions in Mycobacterium tuberculosis infection. Low-dose challenge with fully virulent strains in cynomolgus macaques result in the full clinical spectrum seen in humans, including latent and active infection. Reagents from humans are usually cross-reactive with macaques, further facilitating the use of this model system to study tuberculosis. Finally, macaques develop the spectrum of granuloma types seen in humans, providing a unique opportunity to investigate bacterial and host factors at the local (lung and lymph node) level. Here, we review the past decade of immunology and pathology studies in macaque models of tuberculosis.
Source: Immunological Reviews
DOI: 10.1111/imr.12258
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine, Defining how the spectrum of latency affects reactivation of TB, TNF and Granuloma Formation in Tuberculosis, Predicting immune responses that correlate with protection against tuberculosis, B cells and humoral immunity in tuberculosis, G7024365825, CD4 T Cells in Tuberculosis, A multi-scale model to predict outcomes of immunomodulation and drug therapy duri
OpenAlex ID: W2089403231
